Validation of the cognitive stimulation therapy (CST) program for people with dementia in Portugal.

Cognitive stimulation therapy cognition cognitive stimulation dementia non-pharmacological therapy program validation quality of life

Journal

Aging & mental health
ISSN: 1364-6915
Titre abrégé: Aging Ment Health
Pays: England
ID NLM: 9705773

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 23 10 2020
medline: 24 6 2021
entrez: 22 10 2020
Statut: ppublish

Résumé

Cognitive Stimulation Therapy (CST) is considered a gold-standard, evidence-based and cost-effective approach to improve cognitive function and quality of life of people with mild to moderate dementia. To validate CST for the Portuguese population and test its effectiveness. A single-blind, multi-center, randomized controlled trial recruited 112 older people with dementia. The primary outcome measure was cognition and secondary measures were quality of life, communication, autonomy, anxiety, depression, and global functioning. We also explored whether CST benefits people differently according to context, gender and level of cognitive reserve. Fifty-five people were randomized to the intervention and 57 to the control group. In the post-test, the intervention group significantly improved relative to controls in cognition (ADAS-Cog, Group CST is valid for the Portuguese population with benefits for people with mild to moderate dementia.

Sections du résumé

BACKGROUND
Cognitive Stimulation Therapy (CST) is considered a gold-standard, evidence-based and cost-effective approach to improve cognitive function and quality of life of people with mild to moderate dementia.
AIMS
To validate CST for the Portuguese population and test its effectiveness.
METHODS
A single-blind, multi-center, randomized controlled trial recruited 112 older people with dementia. The primary outcome measure was cognition and secondary measures were quality of life, communication, autonomy, anxiety, depression, and global functioning. We also explored whether CST benefits people differently according to context, gender and level of cognitive reserve.
RESULTS
Fifty-five people were randomized to the intervention and 57 to the control group. In the post-test, the intervention group significantly improved relative to controls in cognition (ADAS-Cog,
CONCLUSIONS
Group CST is valid for the Portuguese population with benefits for people with mild to moderate dementia.

Identifiants

pubmed: 33089699
doi: 10.1080/13607863.2020.1836473
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1019-1028

Auteurs

G Alvares-Pereira (G)

Health Sciences Institute, Portuguese Catholic University, Lisboa, Portugal.

M V Silva-Nunes (MV)

Health Sciences Institute, Portuguese Catholic University, Lisboa, Portugal.
Interdisciplinary Health Research Center, Catholic University of Portugal, Lisboa, Portugal.

A Spector (A)

Clinical, Educational & Health Psychology, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH